Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,608 | -3,061 | -10,725 | -9,074 | -4,082 |
| Depreciation Amortization | 1,157 | 569 | 2,087 | 1,542 | 1,013 |
| Accounts payable and accrued liabilities | -705 | 64 | 458 | 47 | 882 |
| Other Working Capital | -670 | 43 | 337 | -101 | 924 |
| Other Operating Activity | -10 | 161 | 1,014 | 2,139 | -1,604 |
| Operating Cash Flow | $-4,836 | $-2,225 | $-6,829 | $-5,447 | $-2,867 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -24 | -476 | -424 | -364 |
| Investing Cash Flow | $-24 | $-24 | $-476 | $-424 | $-364 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 24,162 | 24,162 | 31,468 | 31,468 | 31,468 |
| End Cash Position | 19,302 | 21,913 | 24,162 | 25,596 | 28,238 |
| Net Cash Flow | $-4,861 | $-2,249 | $-7,306 | $-5,871 | $-3,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,836 | -2,225 | -6,829 | -5,447 | -2,867 |
| Capital Expenditure | -24 | -24 | -476 | -424 | -364 |
| Free Cash Flow | -4,861 | -2,249 | -7,306 | -5,871 | -3,230 |